Why This Small Victory Against Short Sellers Might Be a Big Deal for Biotech Companies

"Back in 2012, Congress reformed intellectual property law to protect tech companies from patent holders that don't seek to make or sell anything, preferring to pursue a strategy of stockpiling patents and suing productive manufacturers for alleged violations. Often trolls seek monetary settlements—a form of perfectly legal extortion—in exchange for dropping patent challenges and returning to their troll lodge."

"Egged on by Silicon Valley, lawmakers in Congress "fixed" the problem by creating a streamlined procedure by which tech companies could preemptively knock out questionable patents and thereby defuse the entire troll gambit. As so often happens, however, the 2012 reform had unintended consequences. Hedge funds began using the accelerated challenge procedure, known as inter partes review, to attack pharmaceutical patents while shorting manufacturers' stock—a way of betting that shares will decline."

From +Bloomberg Business: http://ow.ly/RmcOx 

Why This Small Victory Against Short Sellers Might Be a Big Deal for Biotech Companies
A 2012 reform meant to block patent trolls has opened drug makers to attacks by hedge funds


"As global markets tumbled, investors, strategists and asset managers across the world struggled for words to describe the selloff that wiped $490 billion from emerging-market equities, dragged Saudi stocks into a bear market and pushed Russia’s ruble toward its lowest closing level on record."

From +The Globe and Mailhttp://ow.ly/Rj0Oj

From panic to judgment day, investors struggle to describe rout
Investors, strategists and asset managers across the world struggled for words to describe the selloff


"North American markets plunged at the start of trading this morning, with the Dow losing 1,000 points and the TSX more than 600 points."

"Earlier, U.S. index futures had signalled losses will cascade in the world’s biggest stock market as contracts on the major equity indexes hit their daily loss limits of 5 per cent."

"In a broad selloff spanning all industries, stocks including Apple Inc. and Netflix Inc. slid at least 6 per cent, while slumps in Gilead Sciences Inc. and Biogen Inc. indicated a selloff in biotechnology shares won’t abate. ConocoPhillips and Chevron Corp. lost more than 8.4 per cent as crude fell further."

From +The Globe and Mailhttp://ow.ly/RhTGB

At the open: TSX, Dow bloodied as global selloff intensifies
Dow plunges as much as 1,000 points, TSX more than 600


Cliff on August 18th, 2015
How Norway's trillion-dollar sovereign wealth fund left Alberta in the dust

From +The Globe and Mailhttp://ow.ly/R3KDP

Alberta and Norway: Two oil powers, worlds apart
Decades ago, the governments of Norway and Alberta had similar long-term visions for turning vast resource riches into public prosperity. Now, a global plunge in oil prices has revealed stark differences in their paths – and the size of their rainy-day funds. How Norway’s trillion-dollar juggernaut has left Alberta in its dust


"Surgeons at Boston Children's Hospital started using 3D-printed copies of patients' affected body parts to prepare for procedures last year. Now, that move has helped save the lives of four children aged two months to 16 years old who suffered from life-threatening blood vessel malformation in their brains. Their condition gave ride to distinctive anatomies that one of the hospital's neurosurgeon, Edward Smith, said were really tricky to operate on. So, the doctors used a combination of 3D printing and synthetic resins to conjure up copies of the kids' deformed vessels, along with nearby normal counterparts and surrounding brain anatomy. That gave them the chance to practice extensively beforehand and reduce possible complications on the operating table."

From +Engadgethttp://ow.ly/QwtLo 

Surgeons practice on 3D-printed models for kids’ operations
Doctors at Boston Children’s Hospital used 3D-printed copies of four patients’ blood vessels to practice for their surgeries.